Literature DB >> 12875820

Somatic mosaicism and cancer: inference based on a conditional Luria-Delbrück distribution.

Steven A Frank1.   

Abstract

Somatic mosaicism for mutations in disease-causing genes has been reported in several recent studies. Examples include hemophilia A, many skin disorders, and several cancers such as retinoblastoma and familial adenomatous polyposis. Many of these disorders require multiple mutations in order to express the disease phenotype. For example, two recessive mutations to the retinoblastoma locus are required to initiate retinoblastomal tumors. I develop a mathematical framework for somatic mosaicism in which two recessive mutations cause disease. With my framework, I analyse the following question: Given an observed frequency of cells with two mutations and an easily scored aberrant phenotype, what is the conditional frequency distribution of cells carrying one mutation and therefore susceptible to transformation by a second mutation? This question is important because a high frequency of carrier cells can cause genetic counselors to misdiagnose a mosaic as an inherited heterozygote carrier and because widespread mosaicism can lead to some germline transmission. As more data accumulate, the observed distribution of mosaics can be compared against my predicted distribution. These sorts of studies will contribute to a broader understanding of the distribution of somatic mutations, a central topic in the study of cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12875820     DOI: 10.1016/s0022-5193(03)00117-6

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  13 in total

1.  Evolution of resistance during clonal expansion.

Authors:  Yoh Iwasa; Martin A Nowak; Franziska Michor
Journal:  Genetics       Date:  2006-04       Impact factor: 4.562

Review 2.  Seeing beyond the average cell: branching process models of cell proliferation, differentiation, and death during mouse brain development.

Authors:  Hugh R MacMillan; Michael J McConnell
Journal:  Theory Biosci       Date:  2010-09-08       Impact factor: 1.919

Review 3.  Evolution of acquired resistance to anti-cancer therapy.

Authors:  Jasmine Foo; Franziska Michor
Journal:  J Theor Biol       Date:  2014-03-25       Impact factor: 2.691

Review 4.  Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration.

Authors:  Steven A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 5.  The challenge of drug resistance in cancer treatment: a current overview.

Authors:  Michail Nikolaou; Athanasia Pavlopoulou; Alexandros G Georgakilas; Efthymios Kyrodimos
Journal:  Clin Exp Metastasis       Date:  2018-05-24       Impact factor: 5.150

6.  Ultra-fast local-haplotype variant calling using paired-end DNA-sequencing data reveals somatic mosaicism in tumor and normal blood samples.

Authors:  Subhajit Sengupta; Kamalakar Gulukota; Yitan Zhu; Carole Ober; Katherine Naughton; William Wentworth-Sheilds; Yuan Ji
Journal:  Nucleic Acids Res       Date:  2015-09-29       Impact factor: 16.971

Review 7.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

Review 8.  Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.

Authors:  J Guy Lyons; Erwin Lobo; Anna M Martorana; Mary R Myerscough
Journal:  Clin Exp Metastasis       Date:  2007-12-11       Impact factor: 5.150

9.  The evolution of two mutations during clonal expansion.

Authors:  Hiroshi Haeno; Yoh Iwasa; Franziska Michor
Journal:  Genetics       Date:  2007-12       Impact factor: 4.562

10.  Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells.

Authors:  Patricia M Schnepp; Greg Shelley; Jinlu Dai; Nicole Wakim; Hui Jiang; Atsushi Mizokami; Evan T Keller
Journal:  Mol Cancer Res       Date:  2020-06-08       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.